Study Comparing the Pharmacokinetic of Biosimilar Eptacog Alfa With Novoseven®, in Patients With Congenital Factor VII Deficiency
Clinical trial NCT03079063 · COMPLETED
Trial details
- NCT number
- NCT03079063
- Sponsor
- AryoGen Pharmed Co.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-03-01
- Primary completion
- 2020-11-30
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.